LMO7 Antibodies

Santa Cruz Biotechnology provides a broad selection of LMO7 monoclonal antibodies for research focused on understanding LMO7 protein functions. LMO7 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LMO7, or LIM domain only 7, is a protein that plays a critical role in cellular processes such as cell adhesion, migration, and differentiation. LMO7 is involved in the regulation of gene expression and has been implicated in various biological pathways. Research has shown LMO7's significance in cancer and developmental biology. Understanding LMO7 function can provide insights into its potential as a therapeutic target. Investigating LMO7 expression patterns and interactions helps reveal its role in normal cellular functions and disease states. Exploring LMO7's molecular mechanisms can lead to breakthroughs in understanding cellular regulation and disease progression. Santa Cruz Biotechnology monoclonal antibodies for LMO7 enable researchers worldwide to advance scientific understanding of cellular processes and disease mechanisms.